Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Down 15% in pre-market
View:
Post by pissed_investor on Mar 15, 2017 8:50am

Down 15% in pre-market

Ouch.  This one has become an 'untouchable', much like VRX.
Comment by Ricky_C on Mar 15, 2017 9:07am
Bought this last year at $ 38.00 and lucky for me sold it at $ 34.00.  Took a loss but in retrospec i made one heck of a move.  All this to say, when i bought, all so called analyst were on the buy buy buy bandwagon estimated eps were expected to be $ 4.00 or $ 5.00 for this year (geez share price will be even less than half of expected eps).  If it smells so good to everyone then ...more  
Comment by Macpoor on Mar 15, 2017 9:10am
Dead right! RBC analysts were saying Nortel at $70 is bargain . Where is freaking Nortel and where are those analysts now?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities